Particulars |
|
|
|
Company Name
| Jagsonpal Pharmaceuticals Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
13.22 |
B.V. (₹) |
64.10 |
Sales(₹ Cr.) |
236.71 |
NP (₹ Cr.) |
28.99 |
NP Var (%) |
58.00 |
Div% |
100.00 |
CPS(₹) |
11.40 |
EPS (₹) |
11.00 |
Traded Value(₹ Lakhs) |
41.83 |
52 Week High |
514.00 |
52 Week Low |
270.00 |
Price BSE |
357.00 |
Price NSE |
358.00 |
Market Capital (₹ Cr.) |
944.89 |
P/C Ratio |
31.30 |
P/E Ratio |
32.60 |
Price Vs.BV |
5.57 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
47.25 |
NP(₹ Cr.) |
3.96 |
NP Var % |
-49.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
226.82 |
OPM |
10.08 |
NP |
20.61 |
NP Var (%) |
5.32 |
EPS |
9.27 |
PE |
38.55 |
|
|